Soiken Holdings Inc
TSE:2385
Soiken Holdings Inc
Soiken Holdings Inc. is engaged in the development of biomarkers and assessment systems. The company is headquartered in Toyonaka-Shi, Osaka-Fu and currently employs 104 full-time employees. The company went IPO on 2003-12-18. The firm operates in six business segments. The Biological Evaluation System segment is engaged in evaluation test of food and research support of medicine. The Healthcare Support segment is engaged in the provision of service about certain health guidance and healthcare insurance. The Cosmetics segment is engaged in manufacturing and sales of cosmetics. The Dietary Supplements segment is engaged in sales of unique dietary supplements. The Marketing segment is engaged in the marketing research of health supplement and sales of energy drink. The Functional Material Development segment is engaged in development and sales of functional materials, such as lactoferrin.
Soiken Holdings Inc. is engaged in the development of biomarkers and assessment systems. The company is headquartered in Toyonaka-Shi, Osaka-Fu and currently employs 104 full-time employees. The company went IPO on 2003-12-18. The firm operates in six business segments. The Biological Evaluation System segment is engaged in evaluation test of food and research support of medicine. The Healthcare Support segment is engaged in the provision of service about certain health guidance and healthcare insurance. The Cosmetics segment is engaged in manufacturing and sales of cosmetics. The Dietary Supplements segment is engaged in sales of unique dietary supplements. The Marketing segment is engaged in the marketing research of health supplement and sales of energy drink. The Functional Material Development segment is engaged in development and sales of functional materials, such as lactoferrin.
